PRELUDE CAPITAL MANAGEMENT, LLC - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 263 filers reported holding CYTOKINETICS INC in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$285,762
-3.4%
9,700
+7.0%
0.02%0.0%
Q2 2023$295,831
+15.1%
9,069
+24.2%
0.02%
+26.7%
Q1 2023$256,957
-39.0%
7,302
-62.5%
0.02%
-25.0%
Q3 2020$421,000
+60.7%
19,464
+75.3%
0.02%
+42.9%
Q2 2020$262,000
+803.4%
11,103
+349.7%
0.01%
+600.0%
Q1 2020$29,000
-65.5%
2,469
-68.9%
0.00%
-33.3%
Q4 2019$84,000
+8300.0%
7,934
+3590.2%
0.00%
Q4 2018$1,000
-99.7%
215
-99.5%
0.00%
-100.0%
Q1 2018$315,000
-16.7%
43,743
-5.6%
0.02%
-23.3%
Q4 2017$378,000
-27.2%
46,338
+29.4%
0.03%
-36.2%
Q3 2017$519,000
+75.3%
35,804
+46.2%
0.05%
+67.9%
Q2 2017$296,000
-7.5%
24,482
-1.6%
0.03%
-9.7%
Q1 2017$320,000
+384.8%
24,869
+360.5%
0.03%
+287.5%
Q4 2016$66,000
+144.4%
5,400
+86.2%
0.01%
+166.7%
Q3 2016$27,000
+92.9%
2,900
+93.3%
0.00%
+50.0%
Q2 2016$14,000
-51.7%
1,500
-46.4%
0.00%
-50.0%
Q4 2015$29,000
-53.2%
2,800
-69.6%
0.00%
-55.6%
Q3 2015$62,000
+121.4%
9,213
+122.0%
0.01%
+125.0%
Q2 2015$28,000
-33.3%
4,150
-33.6%
0.00%
-33.3%
Q1 2015$42,000
-72.7%
6,250
-67.5%
0.01%
-73.9%
Q4 2014$154,000
+126.5%
19,2500.0%0.02%
+130.0%
Q3 2014$68,000
+13.3%
19,250
+53.4%
0.01%
+25.0%
Q2 2014$60,000
+57.9%
12,550
+213.8%
0.01%
+33.3%
Q1 2014$38,000
+5.6%
4,000
-27.3%
0.01%0.0%
Q4 2013$36,0005,5000.01%
Other shareholders
CYTOKINETICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
BVF INC/IL 2,106,989$14,159,0002.50%
Healthcare Value Capital, LLC 100,000$672,0000.71%
First Light Asset Management, LLC 218,792$1,470,0000.69%
IRONWOOD INVESTMENT MANAGEMENT LLC 435,202$2,925,0000.67%
TFS CAPITAL LLC 899,951$6,048,0000.59%
SPHERA FUNDS MANAGEMENT LTD. 422,250$2,838,0000.28%
ALGERT GLOBAL LLC 73,181$492,0000.27%
LANSDOWNE PARTNERS (UK) LLP 2,321,865$15,603,0000.13%
Leisure Capital Management 17,567$118,0000.12%
Rotella Capital Management, Inc. 15,778$106,0000.09%
View complete list of CYTOKINETICS INC shareholders